Cargando…

Leukemoid Reaction in a Severe COVID-19 Patient

Leukemoid reaction is defined by a leukocyte level above 50 x 10(3)/µL with a predominance of mature neutrophils and the presence of immature granulocytic forms in the peripheral blood (left shift). We report a case of a 36-year-old woman with severe coronavirus disease 2019 (COVID-19) infection adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Sene, Diogo R, Watashi, Diego M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432427/
https://www.ncbi.nlm.nih.gov/pubmed/34527502
http://dx.doi.org/10.7759/cureus.17865
_version_ 1783751163251785728
author Sene, Diogo R
Watashi, Diego M
author_facet Sene, Diogo R
Watashi, Diego M
author_sort Sene, Diogo R
collection PubMed
description Leukemoid reaction is defined by a leukocyte level above 50 x 10(3)/µL with a predominance of mature neutrophils and the presence of immature granulocytic forms in the peripheral blood (left shift). We report a case of a 36-year-old woman with severe coronavirus disease 2019 (COVID-19) infection admitted to the ICU with a leukocytosis of 70.9 x 10(3)/µL white blood cells (WBC) throughout her hospitalization. A left shift with bandemia along with toxic granulations was also noticed and further investigation excluded more commonly known causes. A presumptive diagnosis of leukemoid reaction was made secondary to COVID-19 infection; however, it could not be confirmed since workup for lymphoproliferative disorders could not be performed as the patient passed away. The leukemoid reaction could be associated with severe COVID-19 infection; however, more data are needed to evaluate this association.
format Online
Article
Text
id pubmed-8432427
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-84324272021-09-14 Leukemoid Reaction in a Severe COVID-19 Patient Sene, Diogo R Watashi, Diego M Cureus Internal Medicine Leukemoid reaction is defined by a leukocyte level above 50 x 10(3)/µL with a predominance of mature neutrophils and the presence of immature granulocytic forms in the peripheral blood (left shift). We report a case of a 36-year-old woman with severe coronavirus disease 2019 (COVID-19) infection admitted to the ICU with a leukocytosis of 70.9 x 10(3)/µL white blood cells (WBC) throughout her hospitalization. A left shift with bandemia along with toxic granulations was also noticed and further investigation excluded more commonly known causes. A presumptive diagnosis of leukemoid reaction was made secondary to COVID-19 infection; however, it could not be confirmed since workup for lymphoproliferative disorders could not be performed as the patient passed away. The leukemoid reaction could be associated with severe COVID-19 infection; however, more data are needed to evaluate this association. Cureus 2021-09-10 /pmc/articles/PMC8432427/ /pubmed/34527502 http://dx.doi.org/10.7759/cureus.17865 Text en Copyright © 2021, Sene et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Sene, Diogo R
Watashi, Diego M
Leukemoid Reaction in a Severe COVID-19 Patient
title Leukemoid Reaction in a Severe COVID-19 Patient
title_full Leukemoid Reaction in a Severe COVID-19 Patient
title_fullStr Leukemoid Reaction in a Severe COVID-19 Patient
title_full_unstemmed Leukemoid Reaction in a Severe COVID-19 Patient
title_short Leukemoid Reaction in a Severe COVID-19 Patient
title_sort leukemoid reaction in a severe covid-19 patient
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432427/
https://www.ncbi.nlm.nih.gov/pubmed/34527502
http://dx.doi.org/10.7759/cureus.17865
work_keys_str_mv AT senediogor leukemoidreactioninaseverecovid19patient
AT watashidiegom leukemoidreactioninaseverecovid19patient